DEVELOPMENT AND EVALUATION OF A CARE PATHWAY FOR EVALUATION AND MANAGEMENT OF THE RESPIRATORY SYNDROMES OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) [CAPRESA]
$2,311,734FY2025Defense Health AgencyDOD
Denver Research Institute, Denver CO
Denver Research Institute, Denver CO